腹腔镜Roux-en-Y胃旁路术与单吻合口胃旁路术对血糖控制及2型糖尿病缓解的影响:多中心随机对照试验(DIABAR试验)研究方案
DIABAR试验是一项开放、多中心、随机对照临床试验,计划纳入220例接受降糖药物治疗的重度肥胖2型糖尿病患者,按1:1随机分配至腹腔镜Roux-en-Y胃旁路术(RYGB)或单吻合口胃旁路术(OAGB),随访10年。主要结局为12个月随访时的血糖控制,次要结局涵盖体重、手术并发症、心理状态与生活质量、血糖耐受与胰岛素敏感性、2型糖尿病缓解、肝脏活检非酒精性脂肪性肝病/非酒精性脂肪性肝炎、口腔与粪便微生物组等。
要点
- DIABAR试验为开放、多中心随机对照临床试验,计划纳入220例重度肥胖2型糖尿病患者,随访10年。
- 患者按1:1随机分配至RYGB或OAGB,主要结局为12个月随访时的血糖控制。
- 次要结局包括体重、手术并发症、心理状态与生活质量、混合餐试验测定的血糖耐受与胰岛素敏感性、2型糖尿病缓解及肝脏活检等。
核心结论
- DIABAR试验是少数主要旨在评估重度肥胖2型糖尿病患者接受RYGB与OAGB后血糖反应的随机对照试验之一。
- 试验次要目标为通过识别微生物、免疫和代谢标志物加深对重度肥胖患者2型糖尿病缓解机制的理解,并比较RYGB与OAGB的并发症和副作用。
研究设计与样本
- DIABAR试验为开放、多中心、随机对照临床试验,随访10年。
- 计划纳入220例诊断为2型糖尿病并接受降糖药物治疗的重度肥胖患者。
- 患者按1:1比例随机分配至腹腔镜Roux-en-Y胃旁路术(RYGB)或腹腔镜单吻合口胃旁路术(OAGB)。
关键数值与推荐
- 主要结局为12个月随访时的血糖控制。
- 次要结局包括体重减轻、手术并发症、心理状态与生活质量、饮食行为、胃肠道症状、重复血液检查以识别随时间的变化、混合餐试验测定的血糖耐受与胰岛素敏感性、2型糖尿病缓解、肝脏活检中非酒精性脂肪性肝病/非酒精性脂肪性肝炎的存在、口腔与粪便微生物组、心血管表现、胆汁酸组成以及胆结石形成倾向。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Metabolic surgery induces rapid remission of type 2 diabetes mellitus (T2DM). There is a paucity of high level evidence comparing the efficacy of the laparoscopic Roux-en-Y gastric bypass (RYGB) and the laparoscopic one-anastomosis gastric bypass (OAGB) in glycemic control. Also, the mechanisms that drive the conversion of T2DM in severe obese subjects to euglycemia are poorly understood. METHODS: The DIABAR-trial is an open, multi-center, randomized controlled clinical trial with 10 years follow-up which will be performed in 220 severely obese patients, diagnosed with T2DM and treated with glucose-lowering agents. Patients will be randomized in a 1:1 ratio to undergo RYGB or OAGB. The primary outcome is glycemic control at 12 months follow-up. Secondary outcome measures are diverse and include weight loss, surgical complications, psychologic status and quality of life, dietary behavior, gastrointestinal symptoms, repetitive bloodwork to identify changes over time, glucose tolerance and insulin sensitivity as measured by mixed meal tests, remission of T2DM, presence of non-alcoholic fatty liver disease/non-alcoholic steatohepatitis in liver biopsy, oral and fecal microbiome, cardiovascular performance, composition of bile acids, and the tendency to develop gallstones. DISCUSSION: The DIABAR-trial is one of the few randomized controlled trials primarily aimed to evaluate the glycemic response after the RYGB and OAGB in severe obese patients diagnosed with T2DM. Secondary aims of the trial are to contribute to a deeper understanding of the mechanisms that drive the remission of T2DM in severe obese patients by identification of microbial, immunological, and metabolic markers for metabolic response and to compare complications and side effects of RYGB and OAGB. TRIAL REGISTRATION: ClinicalTrials.gov NCT03330756 ; date first registered: October 13, 2017.
引用
- van Rijswijk A, van Olst N, Meijnikman AS, et al. The effects of laparoscopic Roux-en-Y gastric bypass and one-anastomosis gastric bypass on glycemic control and remission of type 2 diabetes mellitus: study protocol for a multi-center randomized controlled trial (the DIABAR-trial). Trials. 2022. PMID: 36273149. doi:10.1186/s13063-022-06762-3
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。